The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Increase Is Anticipated For The Cardiac Biomarkers Market Over The 2026–2030 Period?
The cardiac biomarkers market has experienced rapid expansion recently. Its value is projected to rise from $21.19 billion in 2025 to $24.22 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.3%. Historically, this growth can be ascribed to a higher occurrence of cardiovascular ailments, the increased availability of emergency cardiac care services, the wider acceptance of laboratory diagnostics, the expanding application of biomarker-driven diagnoses, and advancements in immunoassay technologies.
The cardiac biomarkers market is poised for significant expansion in the coming years. Its value is expected to reach $42.21 billion by 2030, growing at a compound annual growth rate (CAGR) of 14.9%. This anticipated growth during the forecast period stems from factors such as increasing demand for quick cardiac diagnostics, the rising adoption of decentralized testing models, the expansion of preventive cardiology screening, increased investments in advanced diagnostic platforms, and the growing integration of digital health analytics. Major trends predicted for this period encompass the increasing use of high-sensitivity troponin tests, a rise in point-of-care cardiac testing, greater demand for rapid diagnostic kits, the broadening of multiplex cardiac biomarker panels, and an intensified focus on early cardiac risk detection.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10234&type=smp
Which Major Factors Are Driving The Expansion Of The Cardiac Biomarkers Market?
The projected increase in healthcare spending is expected to boost the expansion of the cardiac biomarker market moving forward. These health expenditures cover all financial outlays associated with providing health services, family planning programs, nutrition initiatives, and emergency assistance with a primary focus on health. Healthcare investment in cardiac biomarkers aims to improve early detection, facilitate personalized treatment, and enable efficient allocation of resources, potentially leading to a reduction in the overall costs related to cardiovascular diseases. For example, in May 2024, a report from the Office for National Statistics, a UK-based government department, revealed that total healthcare expenditure rose by 5.6% in nominal terms from 2022 to 2023, a notable contrast to the mere 0.9% growth observed in 2022. Thus, the growth of the cardiac biomarker market is being propelled by the upward trend in healthcare expenditures.
How Is The Cardiac Biomarkers Market Segmented Across Key Categories?
The cardiac biomarkers market covered in this report is segmented –
1) By Biomarker Type: Creatine Kinase (CK-Mb), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA)
2) By Location Of Testing: Point Of Care Testing, Laboratory Testing
3) By Application: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Atherosclerosis, Other Applications
4) By End User: Hospitals, Specialty Clinics
Subsegments:
1) By Creatine Kinase (CK-Mb): CK-Mb Test Kits, CK-Mb Diagnostic Panels
2) By Troponins: Troponin I Test Kits, Troponin T Test Kits, Troponin Diagnostic Panels
3) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels
4) By Natriuretic Peptides (BNP And NT-proBNP): BNP Test Kits, NT-ProBNP Test Kits, Natriuretic Peptides Diagnostic Panels
5) By Ischemia Modified Albumin (IMA): IMA Test Kits, IMA Diagnostic Panels
Which Upcoming Trends Are Expected To Influence The Cardiac Biomarkers Market?
Leading companies in the cardiac biomarker markets are primarily concentrating on the creation of innovative assays to expand their product ranges, with the goal of improving patient outcomes and meeting existing medical needs. Such advanced biomarker assays are instrumental in driving progress in cardiac diagnostics, leading to greater accuracy and broadened diagnostic capabilities. For example, in October 2023, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., a Chinese provider of medical devices and solutions, unveiled two new high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. These new offerings further strengthen Mindray’s comprehensive portfolio of cardiac biomarkers, crucial for the diagnosis and management of cardiovascular diseases (CVDs).
Who Are The Dominant Players Shaping The Cardiac Biomarkers Market Landscape?
Major companies operating in the cardiac biomarkers market are F. Hoffmann-La Roche AG, Siemens Healthineers AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Bio-Rad Laboratories Inc, bioMérieux SA, QuidelOrtho Corporation, Randox Laboratories Ltd, Becton Dickinson and Company, Tosoh Corporation, PerkinElmer Inc, Grifols S.A., DiaSorin S.p.A., Sysmex Corporation, Lepu Medical Technology (Beijing) Co. Ltd, Mindray Bio-Medical Electronics Co. Ltd, Fujirebio Holdings Inc, Euroimmun AG, Beckman Coulter Inc, Trinity Biotech plc
Read the full cardiac biomarkers market report here:
https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-global-market-report
Which Region Currently Holds The Largest Share Of The Cardiac Biomarkers Market?
North America was the largest region in the cardiac biomarkers market in 2025. The regions covered in the cardiac biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Cardiac Biomarkers Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=10234&type=smp
Browse Through More Reports Similar to the Global Cardiac Biomarkers Market 2026, By The Business Research Company
Acoustic Insulation Market Report 2026
https://www.thebusinessresearchcompany.com/report/acoustic-insulation-global-market-report
Automotive Acoustic Materials Market Report 2026
https://www.thebusinessresearchcompany.com/report/automotive-acoustic-materials-global-market-report
Automotive Acoustic Engineering Services Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model